149 related articles for article (PubMed ID: 11803168)
1. Importance of periodontal disease in the kidney patient.
Craig RG; Spittle MA; Levin NW
Blood Purif; 2002; 20(1):113-9. PubMed ID: 11803168
[TBL] [Abstract][Full Text] [Related]
2. Association between periodontitis and systemic inflammation in patients with end-stage renal disease.
Nadeem M; Stephen L; Schubert C; Davids MR
SADJ; 2009 Nov; 64(10):470-3. PubMed ID: 20306866
[TBL] [Abstract][Full Text] [Related]
3. Serum markers of periodontal disease status and inflammation in hemodialysis patients.
Rahmati MA; Craig RG; Homel P; Kaysen GA; Levin NW
Am J Kidney Dis; 2002 Nov; 40(5):983-9. PubMed ID: 12407643
[TBL] [Abstract][Full Text] [Related]
4. Interactions between chronic renal disease and periodontal disease.
Craig RG
Oral Dis; 2008 Jan; 14(1):1-7. PubMed ID: 18173441
[TBL] [Abstract][Full Text] [Related]
5. Periodontitis and the end-stage renal disease patient receiving hemodialysis maintenance therapy.
Craig RG; Kotanko P
Compend Contin Educ Dent; 2009 Oct; 30(8):544, 546-52. PubMed ID: 19824568
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, cardiovascular disease and destructive periodontal diseases. The evolving role of the dental profession.
Craig RG
N Y State Dent J; 2004; 70(5):22-6. PubMed ID: 15332563
[TBL] [Abstract][Full Text] [Related]
7. Effect of nonsurgical periodontal treatment on C-reactive protein levels in maintenance hemodialysis patients.
Yazdi FK; Karimi N; Rasouli M; Roozbeh J
Ren Fail; 2013; 35(5):711-7. PubMed ID: 23534529
[TBL] [Abstract][Full Text] [Related]
8. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
[TBL] [Abstract][Full Text] [Related]
9. Relationship of destructive periodontal disease to the acute-phase response.
Craig RG; Yip JK; So MK; Boylan RJ; Socransky SS; Haffajee AD
J Periodontol; 2003 Jul; 74(7):1007-16. PubMed ID: 12931763
[TBL] [Abstract][Full Text] [Related]
10. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
[TBL] [Abstract][Full Text] [Related]
11. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients.
Siribamrungwong M; Puangpanngam K
Ren Fail; 2012; 34(2):171-5. PubMed ID: 22229644
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and inflammation in hemodialysis patients.
Spittle MA; Hoenich NA; Handelman GJ; Adhikarla R; Homel P; Levin NW
Am J Kidney Dis; 2001 Dec; 38(6):1408-13. PubMed ID: 11728983
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of aortic valve alterations in haemodialysis patients is associated with signs of chronic inflammation.
Schönenberger A; Winkelspecht B; Köhler H; Girndt M
Nephron Clin Pract; 2004; 96(2):c48-55. PubMed ID: 14988598
[TBL] [Abstract][Full Text] [Related]
16. Linkage of elevated CaxPO4 product with inflammation in maintenance hemodialysis patients.
Nasri H
Minerva Urol Nefrol; 2006 Dec; 58(4):339-45. PubMed ID: 17268399
[TBL] [Abstract][Full Text] [Related]
17. [Chronic inflammation and cardiovascular risk in hemodialysis].
Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
[TBL] [Abstract][Full Text] [Related]
18. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?
Arici M; Walls J
Kidney Int; 2001 Feb; 59(2):407-14. PubMed ID: 11168922
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
